Quadrant Private Wealth Management, LLC
Source: SEC Form 13F · as of Mar 2026Quadrant Private Wealth Management, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $22.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$22.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 22,377 | $5.5M |
| ABBVAbbVie Inc. | 20,478 | $4.5M |
| MRKMerck & Co., Inc. | 30,927 | $3.7M |
| PFEPFIZER INC | 99,530 | $2.8M |
| LLYELI LILLY & Co | 2,610 | $2.4M |
| BMYBRISTOL MYERS SQUIBB CO | 12,163 | $738K |
| ZTSZoetis Inc. | 5,240 | $619K |
| MCKMcKesson Corporation | 558 | $484K |
| GILDGILEAD SCIENCES, INC. | 2,802 | $391K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,314 | $356K |
| SUNSUNSET ISLAND GROUP | 4,256 | $276K |
| PMPhilip Morris International Inc | 1,499 | $250K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,370 | $243K |
| AZNASTRAZENECA PLC | 1,220 | $241K |
| RDYDR REDDYS LABORATORIES LTD | 12,532 | $174K |
| IPSCCentury Therapeutics, Inc. | 20,022 | $45K |
| LCTXLineage Cell Therapeutics, Inc. | 10,000 | $16K |
| CYPHCYPHERPUNK TECHNOLOGIES INC. | 11,200 | $9K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.